Please Note: Harmony Biosciences recently announced results from the Phase 3 RECONNECT clinical trial. Unfortunately, the study did not meet its main goal, which can feel disappointing for families following the progress. See the letter from Harmony and we also break down what this means and what comes next.
The team at Harmony Biosciences is excited to share that they have reached their enrollment goal for the Phase 3 RECONNECT trial and screening has officially closed.
A message to the Fragile X community from Dr. Kumar Budur, Chief Medical & Scientific Officer at Harmony Biosciences:
